生物系统工程(01355)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01355 生物系统工程

交易中 09-09 14:00:07

0.135

-0.002

-1.46%

最高0.138	最低0.125	成交量240.00万
今开0.133	昨收0.137	日振幅9.49%
总市值2.42亿	流通市值2.42亿	总股本17.90亿
成交额32.04万	换手率0.13%	流通股本17.90亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01355","market":"HK","secType":"STK","nameCN":"生物系统工程","latestPrice":0.135,"timestamp":1788926051580,"preClose":0.137,"halted":0,"volume":2400000,"delay":0,"changeRate":-0.014598540145985413,"floatShares":1789999999,"shares":1789999999,"eps":-0.0451,"marketStatus":"交易中","change":-0.002,"latestTime":"09-09 14:00:07","open":0.133,"high":0.138,"low":0.125,"amount":320440,"amplitude":0.094891,"askPrice":0.142,"askSize":260000,"bidPrice":0.135,"bidSize":40000,"shortable":0,"etf":0,"ttmEps":-0.007713,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1788941400000},"marketStatusCode":2,"adr":0,"listingDate":1310659200000,"exchange":"SEHK","adjPreClose":0.137,"openAndCloseTimeList":[[1788917400000,1788926400000],[1788930000000,1788940800000]],"volumeRatio":12.186865,"lotSize":20000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01355","defaultTab":"news","newsList":[{"id":"2665325555","title":"生物系统工程(01355.HK)按“2供1”基准进行供股而发行5.97亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665325555","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665325555?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:36","pubTimestamp":1788856569,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01355","BK1164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154022517","title":"生物系统工程完成供股596,532,580股 占原已发行股本50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154022517","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154022517?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:35","pubTimestamp":1788856553,"startTime":"0","endTime":"0","summary":"生物系统工程有限公司（股票代码：01355）于2026年9月8日公告，基于每持有两股现有股份可认购一股供股股份的基准，非包销供股方式共发行596,532,580股新股，占该公司现有已发行股份总数（不包括库存股份）约50%。本次供股发行价为每股0.068港元，对应募集金额约4,056.42万港元。发行完成后，公司已发行股本由1,193,065,160股增至1,789,597,740股，库存股份数量保持不变。\n公告同时披露，公司已取得董事会正式授权开展此次股份发行，并确认已遵守香港联合交易所有限公司证券上市规则及其他相关法律法规的规定。该公告由公司秘书李柏聪签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"生物系统工程完成供股596,532,580股 占原已发行股本50%","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665325160","title":"生物系统工程：9月8日发行新股59653.26万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665325160","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665325160?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:35","pubTimestamp":1788856500,"startTime":"0","endTime":"0","summary":"南财智讯9月8日电，生物系统工程（01355.HK）发布翌日披露报表，公司于2026年9月8日完成供股，发行新股59653.26万股，占供股前已发行股份（不包括库存股份）数目50%，每股发行价0.068港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609083868078460.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609083868078460.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665155319","title":"生物系统工程(01355)：2.56亿股未获认购供股股份已成功配售","url":"https://stock-news.laohu8.com/highlight/detail?id=2665155319","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665155319?lang=zh_cn&edition=full","pubTime":"2026-09-07 19:35","pubTimestamp":1788780913,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物系统工程(01355)发布公告，于2026年9月2日(星期三)下午四时正(即配售代理配售配售股份的最后时限)，2.56亿股未获认购供股股份已根据配售事项按每股股份0.068港元的价格(相等于认购价)成功配售予不少于六名承配人。因此，概无净收益可供分派予不行动股东。供股章程所载供股及配售事项的所有条件均已获达成，供股及配售事项于2026年9月3日(星期四)下午四时正成为无条件。根据供股接纳结果及配售事项结果，将予配发及发行的供股股份为 5.97亿股供股股份，占供股项下可供认购的供股股份总数的100%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168343030","title":"生物系统工程（01355.HK）完成供股 募集净额约3,900万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168343030","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168343030?lang=zh_cn&edition=full","pubTime":"2026-09-07 19:31","pubTimestamp":1788780707,"startTime":"0","endTime":"0","summary":"2026年9月7日，生物系统工程有限公司公布按“每持有2股现有股份可认购1股”基准进行的供股最终结果。公司合共发行5.97亿股供股股份，认购价为每股0.068港元，募集资金总额约4,000万港元，扣除相关开支后所得款项净额约3,900万港元。余下未获认购的2.56亿股已通过补偿安排全部配售予不少于6名独立承配人，配售价同为每股0.068港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159304947","title":"生物系统工程2026年中期营收2,508.60万元，经调整净利润5,272.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159304947","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159304947?lang=zh_cn&edition=full","pubTime":"2026-09-07 16:57","pubTimestamp":1788771464,"startTime":"0","endTime":"0","summary":"生物系统工程公布的2026年中期财报显示，报告期内，公司营收为25,086千港元，相比去年同期的25,445千港元下降约1.4%。经调整净利润达52,726千港元，相较上年同期净亏损14,773千港元，本期实现扭亏为盈。经营活动现金流净额合计7,185千港元。从成本结构看，报告期内公司总经营成本由上一年同期的22,505千港元下降至19,797千港元，降幅约12%。医疗保健及美容业务在报告期内实现收入16,202千港元，相比上年同期的11,866千港元增长约36.6%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"生物系统工程2026年中期营收2,508.60万元，经调整净利润5,272.60万元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117412509","title":"生物系统工程更新8月股份变动月报表，法定股本提高至港币1亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1117412509","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117412509?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:16","pubTimestamp":1788261360,"startTime":"0","endTime":"0","summary":"生物系统工程有限公司于2026年9月1日发布2026年8月31日止月份的证券变动月报表。公告显示，公司已按2026年8月25日股东特别大会通过的决议，将法定股本由原本的港币20,000,000增至港币100,000,000。公司未发生购回、注销或库藏股变化，库存股份数为零。公司于2026年8月5日发行了总额港币50,000,000的零息无抵押可换股债券，拟于2031年到期，截至报告期末上述债券尚未转换为新股，且已发行股份总数不变。报告显示，公告由公司秘书李桕聪签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663676001","title":"生物系统工程(01355)发布中期业绩 股东应占溢利2114.9万港元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2663676001","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663676001?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:35","pubTimestamp":1788186920,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物系统工程(01355)发布截至2026年6月30日止6个月中期业绩，收益2508.6万港元，同比减少1.41%;公司拥有人应占溢利2114.9万港元，去年同期亏损1348.4万港元;每股基本盈利1.77港仙。公告称，收入净减少主要来自医疗保健及美容业务分部的收益增加及来自住宿业务分部的收益减少。于本期间，集团取得公司拥有人应占溢利约 2114.9万港元，而上一财政年度同期则取得公司拥有人应占亏损约1348.4万港元。差额主要是由于提前终止租赁的收益约6578.9万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110651358","title":"生物系统工程2026年上半年营收2508.6万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110651358","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110651358?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:23","pubTimestamp":1788186191,"startTime":"0","endTime":"0","summary":"截至2026年6月30日止六个月，生物系统工程录得营收约2508.6万港元，同比下降约1.4%。其中，住宿业务营收约888.4万港元，同比下降约34.6%；医疗保健及美容业务营收约1620.2万港元，同比增幅约36.5%。期内经营活动净现金流约718.5万港元。管理层表示，总经营成本在内的多项费用得以有效控制，期内经营成本约1979.7万港元，同比下降约12%。研发投入约132.5万港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"生物系统工程2026年上半年营收2508.6万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194261000","title":"生物系统工程(01355)获股东全票通过将法定股本增至1亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194261000","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194261000?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:35","pubTimestamp":1787654142,"startTime":"0","endTime":"0","summary":"生物系统工程8月25日公告称，公司于2026年8月25日举行的股东特别大会上，以投票表决方式通过有关增加法定股本的普通决议案。会议批准将公司法定股本由2,000万港元提升至1亿港元。由于赞成票比例不少于50%，该决议案正式获通过。\\n\\n公告显示，截至股东特别大会当日，公司已发行股本为1,193,065,160股。会议中并无股份须放弃投票或限制投票，亦无人预先表示反对或弃权。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191966696","title":"生物系统工程（01355）供股认购率57.09%，256,000,718股将按补偿安排配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1191966696","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191966696?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:26","pubTimestamp":1787653569,"startTime":"0","endTime":"0","summary":"生物系统工程有限公司8月25日披露，其按“每持有两股现有股份获配发一股”基准、每股认购价0.068港元进行的供股已于2026年8月18日16时截止接纳。截至记录日期，供股共计发售596,532,580股。公司共收到15份有效接纳，涉及340,531,862股，认购率约57.09%。尚有256,000,718股、占发售股份42.91%未获认购，须按补偿安排处理。未足额行使供股权的股东及不合资格股东持股比例或被摊薄。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735336","title":"生物系统工程(01355.HK)供股获有效接纳约57.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735336","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662735336?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:23","pubTimestamp":1787653418,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01355","BK1164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278064","title":"生物系统工程(01355)发盈喜，预期中期股东应占净溢利约2000万港元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278064","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661278064?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:53","pubTimestamp":1787568792,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物系统工程(01355)发布公告，与截至2025年6月30日止6个月的本公司拥有人应占亏损约1350万港元相比，预期截至2026年6月30日止6个月本集团将取得本公司拥有人应占净溢利约2000万港元。预期取得净溢利主要由于(其中包括)提前终止租赁的收益约6580万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"生物系统工程(01355)发盈喜，预期中期股东应占净溢利约2000万港元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114945150","title":"生物系统工程(01355)发布正面盈利预告：上半年预计录得约2000万港元净利润","url":"https://stock-news.laohu8.com/highlight/detail?id=1114945150","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114945150?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:50","pubTimestamp":1787568650,"startTime":"0","endTime":"0","summary":"生物系统工程有限公司（01355，以下简称“公司”）8月24日公告，根据对截至2026年6月30日止六个月未经审计综合管理账目的初步评估，公司预计将录得归属于公司股东的净利润约2000万港元，而上年同期则录得约1350万港元的净亏损。\n公司表示，业绩由亏转盈的主要原因之一，是报告期内确认了约6580万港元的提前终止租赁收益。\n公司强调，上述数据基于董事会现有资料的初步评估，未经审核委员会审阅，最终未经审计中期业绩将于2026年8月31日或之前公布。\n公司提醒股东及潜在投资者在买卖公司股份时需保持审慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143924248","title":"生物系统工程（01355）将于8月31日审议2026年中期业绩及分红事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1143924248","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143924248?lang=zh_cn&edition=full","pubTime":"2026-08-19 18:20","pubTimestamp":1787134832,"startTime":"0","endTime":"0","summary":"生物系统工程有限公司（01355）董事会宣布，公司已排定于2026年8月31日（星期一）举行董事会会议。届时，董事会将考虑并批准公布截至2026年6月30日止六个月的未经审计中期业绩，并视情况审议及批准建议派发中期股息（如有）。\n公告显示，截至公告日期，公司董事会成员包括：\n1. 执行董事：李芷欣女士  \n2. 非执行董事：张政武先生、胡性龙先生  \n3. 独立非执行董事：吴吉林先生、林长盛先生、苏彦威先生\n该公告发布于2026年8月19日。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190088109","title":"生物系统工程(01355)完成发行5,000万港元可换股债券 最高将把股本扩大至15.16亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1190088109","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190088109?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:12","pubTimestamp":1785921137,"startTime":"0","endTime":"0","summary":"生物系统工程有限公司8月5日公告，根据特别授权发行的可换股债券已于当日完成。此次发行本金总额为5,000万港元的可换股债券全部配售予认购人，认购价以抵销贷款方式支付，相关贷款偿还责任已全面履行。截至公告日期，尚无可换股债券被转换。公告显示，可换股债券完成前，公司已发行股份总数为1,193,065,160股。届时，认购人持股将增至668,509,665股，占比44.11%；历宝珊及关文焯的持股数量保持不变，分别占比6.20%及4.36%；公众股东持股仍为687,114,140股，占比45.33%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657512980","title":"生物系统工程(01355)完成发行本金总额为5000万港元的可换股债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2657512980","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657512980?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:06","pubTimestamp":1785920813,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物系统工程(01355)发布公告，于认购及清贘协议所载的所有先决条件已获达成，且已于2026年8月5日完成。于完成后，本金总额为5000万港元的可换股债券已发行予认购人。认购人以抵销抵销贷款的方式支付可换股债券的认购价。本公司就抵销贷款的还款责任已获全面履行。于本公告日期，概无可换股债券予以转换。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BNDW","BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657592915","title":"生物系统工程(01355)拟增加法定股本","url":"https://stock-news.laohu8.com/highlight/detail?id=2657592915","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657592915?lang=zh_cn&edition=full","pubTime":"2026-08-05 12:10","pubTimestamp":1785903012,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物系统工程(01355)发布公告，公司董事会建议通过增设80亿股股份，将本公司法定股本由2000万港元(分为20亿股每股面值0.01港元的本公司股份(股份))增加至1亿港元(分为100亿股股份)，而该等股份于发行后将于各方面与现有股份享有同等地位(增加法定股本)。于本公告日期，已发行11.93亿股股份，而8.069亿股股份为法定但未发行。为应对本集团的潜在增长及发展并为本公司于未来集资时提供更大灵活性，董事会认为增加法定股本符合本公司及其股东(股东)的整体利益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1164","01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129809863","title":"生物系统工程（01355）拟将法定股本由2,000万港元增至1亿港元 以备未来融资需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1129809863","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129809863?lang=zh_cn&edition=full","pubTime":"2026-08-05 12:05","pubTimestamp":1785902748,"startTime":"0","endTime":"0","summary":"2026年8月5日，生物系统工程有限公司发布公告称，董事会建议在股东特别大会上提交普通决议案，拟将公司法定股本由现有的20,000,000港元增至100,000,000港元。换言之，此次将新增8,000,000,000股法定股份，新增股份在发行后与现有股份享有同等地位。截至公告日，公司已发行1,193,065,160股，尚有806,934,840股虽已获授权但未发行。公司表示，扩大法定股本旨在为集团潜在增长及未来融资提供更大灵活性。有关增资的详细信息及股东特别大会通告的通函，预计将于2026年8月5日寄发予股东。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133498766","title":"生物系统工程（01355）拟于2026年8月25日召开股东特别大会 议决增加法定股本至1亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133498766","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133498766?lang=zh_cn&edition=full","pubTime":"2026-08-05 06:05","pubTimestamp":1785881157,"startTime":"0","endTime":"0","summary":"生物系统工程有限公司8月5日公告，将于2026年8月25日15时在香港湾仔港湾道26号华润大厦30楼3008-3009室召开股东特别大会，审议一项普通决议案：。如于大会当日12时正香港天文台发出黑色暴雨警告或八号或以上热带气旋信号，或政府宣布“极端情况”生效，股东特别大会将延期，届时公司将另行公告重新安排的会议时间、地点。截至公告日，公司董事会成员为：执行董事李芷欣；非执行董事张政武、胡性龙；独立非执行董事吴吉林、林长盛、苏彦威。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01355"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.legend-strategy.com","stockEarnings":[{"period":"1week","weight":-0.0552},{"period":"1month","weight":0.0458},{"period":"3month","weight":0.181},{"period":"6month","weight":0.1513},{"period":"1year","weight":1.3621},{"period":"ytd","weight":0.3301}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":-0.0137},{"period":"3month","weight":0.0373},{"period":"6month","weight":-0.0155},{"period":"1year","weight":-0.0124},{"period":"ytd","weight":-0.0122}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"生物系统工程有限公司（原名：朸浚国际集团控股有限公司）是一家主要从事住宿业务的投资控股公司。该公司透过两个分部运营业务。住宿业务分部主要从事住宿运营，提供物业及设施管理服务，同时亦提供住宿咨询服务及其他相关业务。医疗保健及美容业务分部主要销售生物再生、胶原蛋白及抗衰老护肤产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.384615,"avgChangeRate":-0.000587},{"month":2,"riseRate":0.538462,"avgChangeRate":-0.013312},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.0275},{"month":4,"riseRate":0.384615,"avgChangeRate":0.022504},{"month":5,"riseRate":0.461538,"avgChangeRate":0.103733},{"month":6,"riseRate":0.384615,"avgChangeRate":-0.003583},{"month":7,"riseRate":0.307692,"avgChangeRate":-0.034837},{"month":8,"riseRate":0.153846,"avgChangeRate":-0.101562},{"month":9,"riseRate":0.571429,"avgChangeRate":0.09708},{"month":10,"riseRate":0.307692,"avgChangeRate":0.050823},{"month":11,"riseRate":0.153846,"avgChangeRate":-0.055893},{"month":12,"riseRate":0.615385,"avgChangeRate":0.027648}],"exchange":"SEHK","name":"生物系统工程","nameEN":"BIOSYSEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物系统工程(01355)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物系统工程(01355)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物系统工程,01355,生物系统工程股票,生物系统工程股票老虎,生物系统工程股票老虎国际,生物系统工程行情,生物系统工程股票行情,生物系统工程股价,生物系统工程股市,生物系统工程股票价格,生物系统工程股票交易,生物系统工程股票购买,生物系统工程股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物系统工程(01355)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物系统工程(01355)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}